US Stock MarketDetailed Quotes

OCUL Ocular Therapeutix

Watchlist

8.830
+0.310+3.64%

Close Nov 22 16:00 ET

8.830
0.0000.00%

Post 20:01 ET

1.39BMarket Cap-7420P/E (TTM)

Ocular Therapeutix Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-372.83%-36.56M

-23.55%-24.8M

-69.66%-33.89M

-17.84%-70.23M

-32.41%-22.45M

41.29%-7.73M

-84.58%-20.08M

-7.38%-19.97M

9.07%-59.6M

-11.91%-16.96M

Net income from continuing operations

-6,972.29%-36.49M

-111.67%-43.78M

-113.89%-64.85M

-13.65%-80.74M

-88.01%-29.22M

97.87%-516K

-10.21%-20.68M

-141.73%-30.32M

-984.05%-71.04M

-303.69%-15.54M

Operating gains losses

66.16%-7.08M

367.64%3.03M

404.45%33.1M

34.96%-9M

223.59%6.48M

-1,947.35%-20.91M

59.21%-1.13M

194.34%6.56M

82.28%-13.84M

66.97%-5.24M

Depreciation and amortization

7.75%959K

46.63%956K

90.48%920K

41.44%2.98M

95.11%958K

74.85%890K

18.12%652K

-13.29%483K

-12.89%2.11M

-13.86%491K

Other non cash items

-70.03%621K

-54.59%569K

60.26%1.97M

25.82%6.11M

25.55%1.55M

69.14%2.07M

3.98%1.25M

3.54%1.23M

4.86%4.85M

4.12%1.24M

Change In working capital

-119.46%-1.21M

168.34%3.13M

-420.28%-13.01M

-649.37%-7.41M

-206.93%-6.55M

59.01%6.22M

-199.03%-4.58M

50.53%-2.5M

146.50%1.35M

-107.28%-2.14M

-Change in receivables

-100.08%-3K

40.40%-3.69M

-282.59%-367K

-2,454.74%-4.85M

-70.06%-2.59M

447.06%3.72M

-326.97%-6.19M

109.70%201K

97.86%-190K

3.79%-1.52M

-Change in inventory

367.92%142K

-56.45%27K

7.88%-269K

54.28%-331K

88.81%-48K

-17.78%-53K

143.66%62K

-170.37%-292K

-1,377.55%-724K

-1,432.14%-429K

-Change in prepaid assets

-2,515.24%-7.04M

913.07%1.55M

117.83%128K

-620.89%-3.77M

-312.96%-2.93M

-155.69%-269K

-82.39%153K

-986.42%-718K

815.84%723K

18.76%-710K

-Change in payables and accrued expense

107.45%5.9M

671.63%5.44M

-669.68%-12.34M

32.55%1.36M

-172.39%-590K

-4.02%2.84M

-49.86%705K

61.48%-1.6M

-81.44%1.02M

47.11%815K

-Change in other current assets

-19.01%311K

-85.52%54K

-0.96%413K

149.45%1.57M

--396K

--384K

--373K

497.14%417K

-424.97%-3.18M

----

-Change in other current liabilities

-63.74%-447K

63.58%-193K

-49.28%-515K

-166.43%-1.81M

---665K

---273K

---530K

---345K

300.96%2.73M

----

-Change in other working capital

39.69%-79K

-107.36%-62K

63.13%-59K

-55.66%427K

-178.48%-124K

22.02%-131K

349.11%842K

-112.20%-160K

-3.70%963K

--158K

Cash from discontinued investing activities

Operating cash flow

-372.83%-36.56M

-23.55%-24.8M

-69.66%-33.89M

-17.84%-70.23M

-32.41%-22.45M

41.29%-7.73M

-84.58%-20.08M

-7.38%-19.97M

9.07%-59.6M

-11.91%-16.96M

Investing cash flow

Cash flow from continuing investing activities

65.64%-89K

62.71%-742K

92.45%-255K

-63.85%-6.09M

78.65%-459K

67.38%-259K

-302.02%-1.99M

-1,124.28%-3.38M

-211.14%-3.72M

-240.73%-2.15M

Net PPE purchase and sale

65.64%-89K

62.71%-742K

92.45%-255K

-63.85%-6.09M

78.65%-459K

67.38%-259K

-302.02%-1.99M

-1,124.28%-3.38M

-211.14%-3.72M

-240.73%-2.15M

Cash from discontinued investing activities

Investing cash flow

65.64%-89K

62.71%-742K

92.45%-255K

-63.85%-6.09M

78.65%-459K

67.38%-259K

-302.02%-1.99M

-1,124.28%-3.38M

-211.14%-3.72M

-240.73%-2.15M

Financing cash flow

Cash flow from continuing financing activities

-91.96%4.18M

-77.23%2.2M

411,724.36%321.22M

11,580.06%169.83M

23,517.90%108.17M

13,786.36%51.94M

1,856.39%9.65M

-39.53%78K

-49.00%1.45M

-31.33%458K

Net issuance payments of debt

--0

--56.35M

--0

--56.35M

--0

Net common stock issuance

--0

--316.35M

--117.26M

--107.73M

--708K

--8.82M

--0

Proceeds from stock option exercised by employees

6,638.71%4.18M

167.48%2.2M

6,143.59%4.87M

-3.58%1.4M

-3.71%441K

-83.42%62K

66.53%821K

-39.53%78K

-59.28%1.45M

-31.33%458K

Net other financing activities

----

---5.18M

--0

----

Cash from discontinued financing activities

Financing cash flow

-91.96%4.18M

-77.23%2.2M

411,724.36%321.22M

11,580.06%169.83M

23,517.90%108.17M

13,786.36%51.94M

1,856.39%9.65M

-39.53%78K

-49.00%1.45M

-31.33%458K

Net cash flow

Beginning cash position

574.72%461.3M

499.89%484.65M

89.86%197.57M

-37.28%104.06M

-8.47%112.31M

-49.84%68.37M

-45.11%80.79M

-37.28%104.06M

-27.80%165.93M

-32.22%122.71M

Current changes in cash

-173.89%-32.47M

-87.99%-23.35M

1,333.48%287.08M

251.15%93.51M

557.14%85.26M

423.38%43.94M

-14.18%-12.42M

-24.15%-23.27M

3.18%-61.86M

-23.37%-18.65M

End cash Position

281.82%428.83M

574.72%461.3M

499.89%484.65M

89.86%197.57M

-8.47%112.31M

-49.84%68.37M

-45.11%80.79M

-37.28%104.06M

Free cash flow

-358.62%-36.65M

-15.77%-25.54M

-46.21%-34.14M

-20.54%-76.32M

-19.91%-22.91M

42.77%-7.99M

-94.05%-22.07M

-23.71%-23.35M

5.13%-63.32M

-21.06%-19.11M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-372.83%-36.56M	-23.55%-24.8M	-69.66%-33.89M	-17.84%-70.23M	-32.41%-22.45M	41.29%-7.73M	-84.58%-20.08M	-7.38%-19.97M	9.07%-59.6M	-11.91%-16.96M
Net income from continuing operations	-6,972.29%-36.49M	-111.67%-43.78M	-113.89%-64.85M	-13.65%-80.74M	-88.01%-29.22M	97.87%-516K	-10.21%-20.68M	-141.73%-30.32M	-984.05%-71.04M	-303.69%-15.54M
Operating gains losses	66.16%-7.08M	367.64%3.03M	404.45%33.1M	34.96%-9M	223.59%6.48M	-1,947.35%-20.91M	59.21%-1.13M	194.34%6.56M	82.28%-13.84M	66.97%-5.24M
Depreciation and amortization	7.75%959K	46.63%956K	90.48%920K	41.44%2.98M	95.11%958K	74.85%890K	18.12%652K	-13.29%483K	-12.89%2.11M	-13.86%491K
Other non cash items	-70.03%621K	-54.59%569K	60.26%1.97M	25.82%6.11M	25.55%1.55M	69.14%2.07M	3.98%1.25M	3.54%1.23M	4.86%4.85M	4.12%1.24M
Change In working capital	-119.46%-1.21M	168.34%3.13M	-420.28%-13.01M	-649.37%-7.41M	-206.93%-6.55M	59.01%6.22M	-199.03%-4.58M	50.53%-2.5M	146.50%1.35M	-107.28%-2.14M
-Change in receivables	-100.08%-3K	40.40%-3.69M	-282.59%-367K	-2,454.74%-4.85M	-70.06%-2.59M	447.06%3.72M	-326.97%-6.19M	109.70%201K	97.86%-190K	3.79%-1.52M
-Change in inventory	367.92%142K	-56.45%27K	7.88%-269K	54.28%-331K	88.81%-48K	-17.78%-53K	143.66%62K	-170.37%-292K	-1,377.55%-724K	-1,432.14%-429K
-Change in prepaid assets	-2,515.24%-7.04M	913.07%1.55M	117.83%128K	-620.89%-3.77M	-312.96%-2.93M	-155.69%-269K	-82.39%153K	-986.42%-718K	815.84%723K	18.76%-710K
-Change in payables and accrued expense	107.45%5.9M	671.63%5.44M	-669.68%-12.34M	32.55%1.36M	-172.39%-590K	-4.02%2.84M	-49.86%705K	61.48%-1.6M	-81.44%1.02M	47.11%815K
-Change in other current assets	-19.01%311K	-85.52%54K	-0.96%413K	149.45%1.57M	--396K	--384K	--373K	497.14%417K	-424.97%-3.18M	----
-Change in other current liabilities	-63.74%-447K	63.58%-193K	-49.28%-515K	-166.43%-1.81M	---665K	---273K	---530K	---345K	300.96%2.73M	----
-Change in other working capital	39.69%-79K	-107.36%-62K	63.13%-59K	-55.66%427K	-178.48%-124K	22.02%-131K	349.11%842K	-112.20%-160K	-3.70%963K	--158K
Cash from discontinued investing activities
Operating cash flow	-372.83%-36.56M	-23.55%-24.8M	-69.66%-33.89M	-17.84%-70.23M	-32.41%-22.45M	41.29%-7.73M	-84.58%-20.08M	-7.38%-19.97M	9.07%-59.6M	-11.91%-16.96M
Investing cash flow
Cash flow from continuing investing activities	65.64%-89K	62.71%-742K	92.45%-255K	-63.85%-6.09M	78.65%-459K	67.38%-259K	-302.02%-1.99M	-1,124.28%-3.38M	-211.14%-3.72M	-240.73%-2.15M
Net PPE purchase and sale	65.64%-89K	62.71%-742K	92.45%-255K	-63.85%-6.09M	78.65%-459K	67.38%-259K	-302.02%-1.99M	-1,124.28%-3.38M	-211.14%-3.72M	-240.73%-2.15M
Cash from discontinued investing activities
Investing cash flow	65.64%-89K	62.71%-742K	92.45%-255K	-63.85%-6.09M	78.65%-459K	67.38%-259K	-302.02%-1.99M	-1,124.28%-3.38M	-211.14%-3.72M	-240.73%-2.15M
Financing cash flow
Cash flow from continuing financing activities	-91.96%4.18M	-77.23%2.2M	411,724.36%321.22M	11,580.06%169.83M	23,517.90%108.17M	13,786.36%51.94M	1,856.39%9.65M	-39.53%78K	-49.00%1.45M	-31.33%458K
Net issuance payments of debt	--0	--0	--0	--56.35M	--0	--56.35M	--0	--0	--0	--0
Net common stock issuance	--0	--0	--316.35M	--117.26M	--107.73M	--708K	--8.82M	--0	--0	--0
Proceeds from stock option exercised by employees	6,638.71%4.18M	167.48%2.2M	6,143.59%4.87M	-3.58%1.4M	-3.71%441K	-83.42%62K	66.53%821K	-39.53%78K	-59.28%1.45M	-31.33%458K
Net other financing activities	----	----	----	---5.18M	--0	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-91.96%4.18M	-77.23%2.2M	411,724.36%321.22M	11,580.06%169.83M	23,517.90%108.17M	13,786.36%51.94M	1,856.39%9.65M	-39.53%78K	-49.00%1.45M	-31.33%458K
Net cash flow
Beginning cash position	574.72%461.3M	499.89%484.65M	89.86%197.57M	-37.28%104.06M	-8.47%112.31M	-49.84%68.37M	-45.11%80.79M	-37.28%104.06M	-27.80%165.93M	-32.22%122.71M
Current changes in cash	-173.89%-32.47M	-87.99%-23.35M	1,333.48%287.08M	251.15%93.51M	557.14%85.26M	423.38%43.94M	-14.18%-12.42M	-24.15%-23.27M	3.18%-61.86M	-23.37%-18.65M
End cash Position	281.82%428.83M	574.72%461.3M	499.89%484.65M	89.86%197.57M	89.86%197.57M	-8.47%112.31M	-49.84%68.37M	-45.11%80.79M	-37.28%104.06M	-37.28%104.06M
Free cash flow	-358.62%-36.65M	-15.77%-25.54M	-46.21%-34.14M	-20.54%-76.32M	-19.91%-22.91M	42.77%-7.99M	-94.05%-22.07M	-23.71%-23.35M	5.13%-63.32M	-21.06%-19.11M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data